Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1968 2
1969 1
1970 1
1971 2
1972 1
1973 1
1975 12
1976 8
1977 19
1978 25
1979 18
1980 23
1981 17
1982 26
1983 15
1984 23
1985 30
1986 22
1987 31
1988 22
1989 30
1990 34
1991 49
1992 45
1993 63
1994 53
1995 63
1996 59
1997 74
1998 77
1999 49
2000 59
2001 58
2002 67
2003 67
2004 70
2005 80
2006 93
2007 117
2008 75
2009 84
2010 131
2011 157
2012 131
2013 135
2014 131
2015 139
2016 162
2017 118
2018 159
2019 123
2020 138
2021 134
2022 135
2023 140
2024 20

Text availability

Article attribute

Article type

Publication date

PubMed for id: 42164

3,262 results

Results by year

Filters applied: . Clear all
Page 1
[Guidelines for type 1 Gaucher's disease].
Giraldo P; Grupo de Trabajo de las Guías de Actuación. Giraldo P, et al. Med Clin (Barc). 2011 Sep;137 Suppl 1:55-60. doi: 10.1016/S0025-7753(11)70019-7. Med Clin (Barc). 2011. PMID: 22230128 Spanish.
South African guidelines for the management of Gaucher disease, 2011.
Lysosomal Storage Disorder Medical Advisory Board; Bhengu L, Davidson A, du Toit P, Gerntholtz T, Govendragaloo K, Heitner R, Henderson B, Mubaiwa L, Varughese S. Lysosomal Storage Disorder Medical Advisory Board, et al. S Afr Med J. 2012 Jun 20;102(8):697-702. doi: 10.7196/samj.5439. S Afr Med J. 2012. PMID: 22831951
Management of neuronopathic Gaucher disease: revised recommendations.
Vellodi A, Tylki-Szymanska A, Davies EH, Kolodny E, Bembi B, Collin-Histed T, Mengel E, Erikson A, Schiffmann R. Vellodi A, et al. J Inherit Metab Dis. 2009 Oct;32(5):660-664. doi: 10.1007/s10545-009-1164-2. Epub 2009 Aug 5. J Inherit Metab Dis. 2009. PMID: 19655269
Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients.
Weinreb NJ, Aggio MC, Andersson HC, Andria G, Charrow J, Clarke JT, Erikson A, Giraldo P, Goldblatt J, Hollak C, Ida H, Kaplan P, Kolodny EH, Mistry P, Pastores GM, Pires R, Prakash-Cheng A, Rosenbloom BE, Scott CR, Sobreira E, Tylki-Szymańska A, Vellodi A, vom Dahl S, Wappner RS, Zimran A; International Collaborative Gaucher Group (ICGG). Weinreb NJ, et al. Semin Hematol. 2004 Oct;41(4 Suppl 5):15-22. doi: 10.1053/j.seminhematol.2004.07.010. Semin Hematol. 2004. PMID: 15468046
Posterior Segment Changes in Gaucher Disease.
Mueller A, Chang TCP. Mueller A, et al. JAMA Ophthalmol. 2024 Feb 1;142(2):e234744. doi: 10.1001/jamaophthalmol.2023.4744. Epub 2024 Feb 15. JAMA Ophthalmol. 2024. PMID: 38358448
Gaucher Disease: A Glance from a Medicinal Chemistry Perspective.
Prencipe F, Barzan C, Savian C, Spalluto G, Carosati E, De Amici M, Mosconi G, Gianferrara T, Federico S, Da Ros T. Prencipe F, et al. ChemMedChem. 2024 Feb 8:e202300641. doi: 10.1002/cmdc.202300641. Online ahead of print. ChemMedChem. 2024. PMID: 38329692
3,262 results